School of Public Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia.
School of Nursing, Midwifery and Paramedicine, Faculty of Health Sciences, Curtin University, Perth, Western Australia.
Psychooncology. 2019 May;28(5):1110-1118. doi: 10.1002/pon.5065. Epub 2019 Apr 10.
To determine the cost-effectiveness of RT Prepare in reducing breast cancer patients' psychological distress before treatment, compared with usual care.
RT Prepare, an intervention involving patient education and support consultations with a radiation therapist (RT), was implemented at three Australian sites (Australian New Zealand Clinical Trials Registration: ACTRN12611001000998). The primary outcome was change in psychological distress using the Hospital Anxiety and Depression Scale (HADS); secondary outcomes were changes in quality of life (QoL) and additional health service use. Costs (2015 $AU) included consultation time and training delivery. Between-group comparisons of HADS and QoL used generalised linear mixed models, and comparisons of health service use used negative binomial regression. Incremental cost-effectiveness ratios (ICERs) indicated mean costs per 1-point decrease in HADS score. Sensitivity analyses explored variation in facility size and uncertainty in intervention effectiveness.
Among 218 controls and 189 intervention participants, the intervention significantly lowered HADS scores at treatment commencement (adjusted mean difference 1.06 points). There was no significant effect on QoL or additional service use. Mean intervention costs were AU$171 per participant (US$130, €119) mostly related to RT training (approximately AU$142 (US$108, €99). An ICER of $158 (US$120, €110) was estimated. Cost-effectiveness improved in a sensitivity analysis representing a large facility with higher patient numbers.
This study provides new data on the cost-effectiveness of an RT-delivered intervention to reduce psychological distress prior to treatment, which will be useful to inform delivery of similar services. As most costs were upfront, cost-effectiveness would likely improve if implemented as standard care.
比较常规护理与 RT Prepare 在治疗前降低乳腺癌患者心理困扰方面的成本效益。
在澳大利亚的三个地点(澳大利亚和新西兰临床试验注册:ACTRN12611001000998)实施了 RT Prepare,这是一项涉及患者教育和与放射治疗师(RT)进行支持咨询的干预措施。主要结局是使用医院焦虑和抑郁量表(HADS)评估心理困扰的变化;次要结局是生活质量(QoL)和额外的卫生服务使用的变化。成本(2015 澳元)包括咨询时间和培训交付。使用广义线性混合模型比较 HADS 和 QoL 的组间差异,使用负二项回归比较卫生服务使用的差异。增量成本效益比(ICER)表示 HADS 评分每降低 1 分的平均成本。敏感性分析探讨了设施规模的变化和干预效果的不确定性。
在 218 名对照组和 189 名干预组参与者中,干预组在治疗开始时显著降低了 HADS 评分(调整后的平均差异为 1.06 分)。对 QoL 或额外服务使用没有显著影响。平均干预成本为每位参与者 171 澳元(130 美元,119 欧元),主要与 RT 培训有关(约 142 澳元(108 美元,99 欧元)。估计的 ICER 为 158 美元(120 美元,110 欧元)。在代表具有更高患者数量的大型设施的敏感性分析中,成本效益得到了改善。
这项研究提供了新的关于 RT 提供的干预措施在治疗前降低心理困扰的成本效益数据,这将有助于为类似服务的提供提供信息。由于大部分成本是前期的,如果作为标准护理实施,成本效益可能会提高。